Financials
Financial year 2026
EndoCard from Jabbeke, company number BE0697720802, closed financial year 2026 with a result of € 650,049 after tax. For that financial year EndoCard recorded a gross margin of € 998,754 and equity of € 669,936. Compared with financial year 2025, the result moved from € 615,287 to € 650,049. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 23, 2026.
€ 669,936
▲ 6% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 650,049
▲ 6% vs 2025
Profit after tax over the fiscal year.
€ 328,463
▼ 39% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 614,000 paid out
94 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
€ 65,032
▼ 23% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 1.1 million
▼ 8% vs 2025
€ 95,151 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 3,425
▲ 55% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 9,004
▼ 84% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 583,744 | € 949,380 | € 936,150 | € 998,754 | ▲ 7% |
| Profit after taxes | € 246,985 | € 645,661 | € 615,287 | € 650,049 | ▲ 6% |
| Equity | € 265,585 | € 666,246 | € 633,887 | € 669,936 | ▲ 6% |
| Total debts | € 1,722,663 | € 1,655,907 | € 1,690,079 | € 1,711,035 | ▲ 1% |
| Cash | € 190,491 | € 363,040 | € 536,829 | € 328,463 | ▼ 39% |
| Land & buildings | € 1,491,264 | € 1,437,688 | € 1,384,112 | € 1,330,536 | ▼ 4% |
| Retained profit | € 246,985 | € 647,646 | € 615,287 | € 651,336 | ▲ 6% |
| Dividend | € 0 | € 245,000 | € 647,646 | € 614,000 | ▼ 5% |
| Bank debt | € 1,417,936 | € 1,327,081 | € 1,234,816 | € 1,141,119 | ▼ 8% |
| Balance sheet total | € 1,988,248 | € 2,322,152 | € 2,323,966 | € 2,380,970 | ▲ 2% |
Key figures of EndoCard, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to EndoCard?
What happened at EndoCard in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 650,049 (▲ 6% vs 2025). Source: NBB ↗
- New establishment in Brugge. KBO
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
- Nick Hiltrop became a director. NBB
- Joke Hoste became a director. NBB
In short
From € 246,985 profit in 2023 to € 650,049 profit in 2026.
Paid € 706,246 in corporate taxes since 2023.
Best year ever: 2026, with € 650,049 profit.
Paid out € 1.5 million in dividends to the owners in total.
Management
Behind EndoCard are Nick Hiltrop and Joke Hoste.
Directors
According to the 2026 annual accounts
Nick Hiltrop
Director
since 2018
Joke Hoste
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Nieuwenhovedreef 26
8490 Jabbeke
Sint-Lucaslaan 29
8310 Brugge
Active since 7 June 2018
President Kennedylaan(Kor) 4
8500 Kortrijk
Active since 7 June 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0697.720.802
- VAT number
- BE 0697.720.802
- Registered office
- Nieuwenhovedreef 26, 8490 Jabbeke
- Names & denominations
- EndoCard
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 June 2018
- Peppol
- Active · Active since 24 Nov 2024